A modified protocol for rapid desensitization to chemotherapy agents
- 1 September 2016
- journal article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 4 (5) , 1003-1005
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Anaphylaxis to Chemotherapy and Monoclonal AntibodiesImmunology and Allergy Clinics of North America, 2015
- Desensitizations for Chemotherapy and Monoclonal Antibodies: Indications and OutcomesCurrent Allergy and Asthma Reports, 2014
- Desensitization to Chemotherapeutic AgentsThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessmentAllergy, 2013
- General considerations on rapid desensitization for drug hypersensitivity – a consensus statementAllergy, 2010
- Stability of docetaxel diluted to 0.3 or 0.9 mg/mL with 0.9% sodium chloride injection and stored in polyolefin or glass containersAmerican Journal of Health-System Pharmacy, 2009
- Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 casesJournal of Allergy and Clinical Immunology, 2008
- Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatmentsGynecologic Oncology, 2005